Świętokrzyskie Centrum Leczenia Zaburzeń Głosu, Słuchu I Mowy Nzoz Laryngomedsp. z o.o.

Specialist medical practice activities

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2007-04-27
Share capital
51 000,00 PLN
Registered address
Klonowa 55, 25-553 Kielce, Poland

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 441.44kMedianUSD 424.04kAverageUSD 1.68m
Net profit
This companyUSD -637.66MedianUSD 13.22kAverageUSD 129.68k
Operating costs
This companyUSD 437.26kMedianUSD 377.08kAverageUSD 1.50m
Assets
This companyUSD 74.40kMedianUSD 168.58kAverageUSD 1.47m

Bank accounts

Registered as a VAT taxpayer on 2007-04-23. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

MSiG notices

Publication dateEvent
Dec 31, 2015Return of additional payments

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$12,308

Tenders

No recorded participation in tenders.

National Health Fund (NFZ) contracts

Świętokrzyskie Centrum Leczenia Zaburzeń Głosu, Słuchu I Mowy Nzoz Laryngomed has been an NFZ healthcare provider since 2008. In 2026 it is performing 2 contracts with a total value of USD 216.49k. All its contracts were worth USD 2.02m in total.

NFZ contract value by year (in k USD)

Type of careNFZ branchContractsValue in 2026
Ambulatoryjna opieka specjalistycznaświętokrzyskie1USD 216.49k
Zaopatrzenie w wyroby medyczneświętokrzyskie1USD 0.00

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Andrzej Karol Konopka – President of the Management Board

Manner of representation

The members of the management board are authorised to make declarations of will and sign on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
1,020$13,776.34100%

Beneficial owners

Person

Competitors

Change history

DateEvent
2015-09-24PKD change
2007-04-27Entered in the register

FAQ

Last updated: 2026-10-07